Status:
COMPLETED
Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing
Lead Sponsor:
Peking University People's Hospital
Conditions:
Carcinoma
Non-small-cell Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Analyse immune repertoire and genetic mutations of benign and malignant pulmonary nodule，and evaluate peripheral blood detection for identifying nature of pulmonary nodule.
Detailed Description
Early diagnosis of lung cancer is of vital importance in lung cancer treatment. This research will first analyse the features of immune repertoire and genetic mutations from tissue of benign and malig...
Eligibility Criteria
Inclusion
- Sign informed consent and consent to participate in this study;
- Found small nodules in pulmonary by CT and prepare for surgery;
Exclusion
- Malignant tumor history within the past 5 years;
- Receiving chemotherapy, radiotherapy or targeted therapy before surgery;
- Histology confirmed not non-small cell lung cancer
- No matching tissue or blood samplesUnqualified blood samples
Key Trial Info
Start Date :
October 18 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03320044
Start Date
October 18 2017
End Date
December 31 2018
Last Update
January 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University People's Hospital
Beijing, Beijing Municipality, China, 100044